Independent provider comparison

Updated September 21, 2026

MEDVi vs Shed: Which GLP-1 provider is better?

A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.

This content was researched and written with AI assistance. MEDVi referral links are affiliate links: we may earn a commission if you sign up. This is independent information, not medical advice or a clinical review.

By Iacob Pastina, Independent Researcher & Publisher
Reviewed & updated · Cites primary sources (FDA, NEJM, CMS) · Not medical advice
37 providers verified independently·Independent researchHow we rank →

The decision

Which should you choose, MEDVi or Shed?

Short answer: Shed scores higher on our published rubric, 7.8/10 against 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Shed is from $159/mo.

Consider MEDVi if

Users who want both oral and injectable compounded options in one telehealth program.

Consider Shed if

Users who want a price that stays flat as the dose escalates, on a simple compounded GLP-1 program.

Scores follow our published methodology. Partnership status does not change the score or the factual comparison.

MEDVi logo

MEDVi

#25 of 37
5.7/10

Best for users who want both oral and injectable compounded options in one telehealth program.

Visit MEDVi(affiliate link)
Higher Rated
Shed logo

Shed

#7 of 37
7.8/10

Best for users who want a price that stays flat as the dose escalates, on a simple compounded glp-1 program.

Visit Shed

Side by side

MEDVi vs Shed at a glance

Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.

FeatureMEDViShed

Why each one

MEDVi

A daily dissolvable GLP-1 tablet and a weekly compounded injection in one program, plus brand-name Wegovy and Zepbound on a $99 membership.

Shed

One flat price at any dose. Shed holds the monthly price steady as the dose escalates, with semaglutide from $159 and tirzepatide from $239 on the 12-month plans and provider care included.
Our Score5.7/107.8/10
Headline Price$179 first month, then $299/mo(affiliate link)from $159/mo
Medication TypeBothBoth
Insurance AcceptedNoNo

Best For

MEDVi

Users who want both oral and injectable compounded options in one telehealth program

Shed

Users who want a price that stays flat as the dose escalates, on a simple compounded GLP-1 program

Watch out for

MEDVi

FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication

Shed

Brand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure.
Ranking#25#7
Get startedVisit MEDVi(affiliate link)Visit Shed

Trade-offs

Strengths and cautions compared

MEDVi

Pros

  • +One of the few compounded providers offering both oral tablets and injectable semaglutide
  • +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
  • +Sleek onboarding experience with clear progress tracking through their patient portal

1 more documented strengths

  • +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping

Cons

  • −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
  • −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
  • −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148

2 more documented cautions

  • −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
  • −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms

Shed

Pros

  • +One flat price at any dose, Shed's pricing page states the monthly price never rises as the dose escalates
  • +$199/mo is competitively priced for an all-inclusive compounded program with good support
  • +Onboarding is fully online and asynchronous in many states, with same day approval advertised, though Shed says some states require a video visit before treatment

1 more documented strengths

  • +Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

  • −Brand name Wegovy, Zepbound and Foundayo sit behind a separate Shed membership, quoted at $125 a month on all three product pages, with the medication billed on top by the dispensing pharmacy. The small print on the Wegovy and Zepbound pages still says $99, so Shed's own pages disagree on the figure.
  • −Short track record and thin published outcome data. A founding date is not shown on the site's about, contact, terms or FAQ pages (rendered check 2026-09-03), and the best evidence available is a 4.7 Trustpilot score across 1,129 reviews on a profile claimed in April 2025
  • −Shed does not bill insurance, so the compounded program is cash pay, though it accepts HSA and FSA cards, posts downloadable receipts for reimbursement, and includes prior authorization and appeals support on the brand name route

1 more documented cautions

  • −Clinical support is responsive (replies typically within 24 hours) but less proactive than premium platforms; a $49.99/mo premium coaching add-on covers those who want higher touch

Our Verdict

Shed edges out MEDVi with a score of 7.8/10 vs 5.7/10. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Shed is from $159/mo.

Keep narrowing the decision

What should you compare next?

Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both MEDVi and Shed start above the cheapest complete recurring program we track. Across all 37 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.

Reviews and pricing sources

Not sure which one is right for you?

Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.

Still working out whether either one is above board? We check that separately: is MEDVi legit and is Shed legit, with the verification evidence behind each answer.